BAYER PHARMS Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BAYER PHARMS, and what generic and branded alternatives to BAYER PHARMS drugs are available?
BAYER PHARMS has twenty-nine approved drugs.
Drugs and US Patents for BAYER PHARMS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Pharms | BAYCOL | cerivastatin sodium | TABLET;ORAL | 020740-004 | Jun 26, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Bayer Pharms | ADALAT | nifedipine | CAPSULE;ORAL | 019478-002 | Sep 17, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Bayer Pharms | MEZLIN | mezlocillin sodium monohydrate | INJECTABLE;INJECTION | 062333-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Bayer Pharms | MEZLIN | mezlocillin sodium monohydrate | INJECTABLE;INJECTION | 050549-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Bayer Pharms | BAYCOL | cerivastatin sodium | TABLET;ORAL | 020740-001 | Jun 26, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Bayer Pharms | NEO-CORT-DOME | hydrocortisone; neomycin sulfate | CREAM;TOPICAL | 050237-005 | Jun 5, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Bayer Pharms | AZLIN | azlocillin sodium | INJECTABLE;INJECTION | 050562-002 | Sep 3, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BAYER PHARMS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bayer Pharms | BAYCOL | cerivastatin sodium | TABLET;ORAL | 020740-001 | Jun 26, 1997 | 5,006,530 | ⤷ Sign Up |
Bayer Pharms | BAYCOL | cerivastatin sodium | TABLET;ORAL | 020740-005 | May 24, 1999 | 5,006,530 | ⤷ Sign Up |
Bayer Pharms | NIMOTOP | nimodipine | CAPSULE;ORAL | 018869-001 | Dec 28, 1988 | 3,799,934 | ⤷ Sign Up |
Bayer Pharms | BAYCOL | cerivastatin sodium | TABLET;ORAL | 020740-006 | Jul 24, 2000 | 5,177,080 | ⤷ Sign Up |
Bayer Pharms | NIMOTOP | nimodipine | CAPSULE;ORAL | 018869-001 | Dec 28, 1988 | 3,932,645 | ⤷ Sign Up |
Bayer Pharms | BAYCOL | cerivastatin sodium | TABLET;ORAL | 020740-003 | Jun 26, 1997 | 5,177,080 | ⤷ Sign Up |
Bayer Pharms | BAYCOL | cerivastatin sodium | TABLET;ORAL | 020740-004 | Jun 26, 1997 | 5,177,080 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.